source
- U.S. drug shortages climb to 227 active cases in Q2 2026The United States reported a rise in active medication shortages during the second quarter of 2026, with the total reaching 227. The increase signals growing pressure on the pharmaceutical supply…
- San Diego biotech BlossomHill files for IPO to fund EGFR lung-cancer drug programBlossomHill Therapeutics, a San Diego oncology biotech focused on small‑molecule drugs, has filed an S‑1 registration statement to become a public company. The company, founded in February 2024 by…